Prevalence of Emerging Treatment-induced Mutations in Metastatic ER-positive Breast Cancer.
NCT06417801 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2026-03-19
Summary
Observational study on prevalence of emerging ESR1 mutations in liquid biopsy in two cohorts of patients with breast cancer (with and without prior therapies in metastatic setting) in comparison with patient's baseline ESR1 mutation status as defined by tissue profiling.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Rodrigo Dienstmann · Oncoclínicas
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-06-17
- Primary Completion
- 2027-12-30
- Completion
- 2027-12-30
Countries
- Brazil
Study Locations
More Related Trials
-
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before Surgery
NCT06127979 ·Status: RECRUITING ·Phase: NA
-
Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment
NCT02326857 ·Status: COMPLETED
-
Monitoring luminAl Breast Cancer Through the Evaluation of Mutational and epiGeNEtic alteraTIons of Circulating ESR1 DNA
NCT05814224 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Longitudinal Breast Cancer Study
NCT02270931 ·Status: COMPLETED
-
Phase II Study of Systemic Screening in Pathologic Node Positive Breast Cancer
NCT06833502 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Study Assessing EndoPredict® Genomic Test Impact on Shared Decision of Adjuvant Chemotherapy in Patients With ER-positive, Her2-negative Early Breast Cancer
NCT02773004 ·Status: COMPLETED ·Phase: NA
-
Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood & Primary Tumor in ER+/HER2- MBC
NCT04480814 ·Status: COMPLETED
-
Praegnant Breast Cancer: Early/Advanced/Metastatic
NCT02338167 ·Status: RECRUITING
-
PIK3CA Mutational Status Assessment
NCT06706570 ·Status: RECRUITING
-
International Breast Cancer Biomarker,Standard of Care and Real World Outcomes Study
NCT03078036 ·Status: COMPLETED
-
Breast Cancer 2-PREVENT Translational Center of Excellence (TCE) - Metastatic Markers of Recurrent Tumor Phenotype for Breast Cancer
NCT02530008 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer
NCT04145960 ·Status: UNKNOWN
-
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol
NCT02078570 ·Status: UNKNOWN
-
Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer
NCT03786575 ·Status: UNKNOWN ·Phase: NA
-
Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer
NCT02670668 ·Status: UNKNOWN ·Phase: NA
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
Safety of Pregnancy in BRCA Mutated Breast Cancer Patients
NCT03673306 ·Status: COMPLETED
-
Analysis of Prognostic and Predictive Genomic Signatures Using Archival Paraffin-embedded Tumor Specimens in Breast Cancer
NCT01247480 ·Status: UNKNOWN
-
Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery
NCT04145973 ·Status: UNKNOWN
-
The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients
NCT02669745 ·Status: COMPLETED
-
Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
NCT02662868 ·Status: COMPLETED
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
Clinical, Histological and In-depth Molecular Characterization as Well as Experimental Models of Liver Metastasis From Patients With Breast Cancer in Order to Identify New Potential Treatment Avenues.
NCT05720676 ·Status: UNKNOWN
-
Monitoring Early Response to Targeted Therapy in Stage IV HER2+ Breast Cancer Patients With Advanced PET/MR Imaging
NCT04273555 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer
NCT03650803 ·Status: COMPLETED ·Phase: NA